| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood
|
Romano, Isabella G.
|
|
|
42 |
3 |
p. 471-480
|
article
|
| 2 |
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study
|
Langley, Joanne M.
|
|
|
42 |
3 |
p. 713-722
|
article
|
| 3 |
A retrospective cohort study evaluating the incidence of herpes zoster and postherpetic neuralgia after a live attenuated Oka-strain herpes zoster vaccine in a real-world setting in Japan
|
Yaegashi, Makito
|
|
|
42 |
3 |
p. 464-470
|
article
|
| 4 |
Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general in the USA
|
Nguyen, Kimberly H.
|
|
|
42 |
3 |
p. 645-652
|
article
|
| 5 |
Compliance with recommended pneumococcal vaccination schedule in patients treated for rheumatoid arthritis: A retrospective cohort study in the Veterans Affairs population
|
Alvarez, Carlos A.
|
|
|
42 |
3 |
p. 489-495
|
article
|
| 6 |
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants
|
Rozenbaum, Mark H.
|
|
|
42 |
3 |
p. 573-582
|
article
|
| 7 |
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023
|
Seppälä, Elina
|
|
|
42 |
3 |
p. 620-628
|
article
|
| 8 |
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study)
|
Arashiro, Takeshi
|
|
|
42 |
3 |
p. 677-688
|
article
|
| 9 |
Determinants of immunization in polio super high-risk union councils of Pakistan
|
Khan, Ahmad
|
|
|
42 |
3 |
p. 583-590
|
article
|
| 10 |
Do vaccines increase or decrease susceptibility to diseases other than those they protect against?
|
Rubio-Casillas, Alberto
|
|
|
42 |
3 |
p. 426-440
|
article
|
| 11 |
Editorial Board
|
|
|
|
42 |
3 |
p. ii
|
article
|
| 12 |
Estimating county-level vaccination coverage using small area estimation with the National Immunization Survey-Child
|
Seeskin, Zachary H.
|
|
|
42 |
3 |
p. 418-425
|
article
|
| 13 |
Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic
|
Filipas, Dejan K.
|
|
|
42 |
3 |
p. 441-447
|
article
|
| 14 |
Factors associated with parental Human Papillomavirus (HPV) vaccination intention of daughter: A national survey in Finland
|
Hussein, Idil
|
|
|
42 |
3 |
p. 701-712
|
article
|
| 15 |
Fasciola hepatica infection modifies IgG1 specific immune response to foot-and-mouth disease virus induced by vaccination
|
Costa, Monique
|
|
|
42 |
3 |
p. 541-547
|
article
|
| 16 |
Heat-inactivated mycobacteria activate the toll-like receptor 2 and 4 pathways in the zebrafish model of tuberculosis
|
Ferreras-Colino, Elisa
|
|
|
42 |
3 |
p. 403-409
|
article
|
| 17 |
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study
|
Wolff, Marcelo
|
|
|
42 |
3 |
p. 671-676
|
article
|
| 18 |
Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial
|
Kuriyama, Kenji
|
|
|
42 |
3 |
p. 662-670
|
article
|
| 19 |
Immunomodulatory properties of bacteriophage derived dsRNA of different size and their use as anticancer vaccine adjuvants
|
Dobrovolskienė, Neringa
|
|
|
42 |
3 |
p. 512-521
|
article
|
| 20 |
In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: A prespecified analysis of the VIP-ACS trial
|
Fonseca, Henrique Andrade R.
|
|
|
42 |
3 |
p. 496-504
|
article
|
| 21 |
In vivo challenge studies on vaccinated chickens indicate a virus genotype mismatched vaccine still offers significant protection against NDV
|
Mahmood, Sahar
|
|
|
42 |
3 |
p. 653-661
|
article
|
| 22 |
“I shall not poison my child with your human experiment”: Investigating predictors of parents’ hesitancy about vaccinating younger children (<12) in Canada
|
Davidson, Adrienne M.
|
|
|
42 |
3 |
p. 505-511
|
article
|
| 23 |
JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data
|
Rosen, Jennifer B.
|
|
|
42 |
3 |
p. 548-555
|
article
|
| 24 |
Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the Congo
|
Zola Matuvanga, Trésor
|
|
|
42 |
3 |
p. 481-488
|
article
|
| 25 |
Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study
|
Shenton, Priya
|
|
|
42 |
3 |
p. 522-528
|
article
|
| 26 |
Long-term surveillance of invasive pneumococcal disease: The impact of 10-valent pneumococcal conjugate vaccine in the metropolitan region of Salvador, Brazil
|
Reis, Joice Neves
|
|
|
42 |
3 |
p. 591-597
|
article
|
| 27 |
Massachusetts companion program bolsters COVID-19 vaccine rates among seniors
|
Charpignon, Marie-Laure
|
|
|
42 |
3 |
p. 415-417
|
article
|
| 28 |
National immunization technical advisory groups (NITAGs) in the WHO Eastern Mediterranean Region (EMR): A decade of shaping immunization policies, 2010–2021
|
Etapelong Sume, Gerald
|
|
|
42 |
3 |
p. 629-635
|
article
|
| 29 |
Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Quebec, Canada, during the Delta and early Omicron periods
|
Lo, Ernest
|
|
|
42 |
3 |
p. 636-644
|
article
|
| 30 |
Ordered mesoporous silicas for potential applications in solid vaccine formulations
|
Miranda, Matheus C.R.
|
|
|
42 |
3 |
p. 689-700
|
article
|
| 31 |
Parental concerns and vaccine hesitancy against COVID-19 vaccination for children in Greece: A cross-sectional survey
|
Steletou, E.
|
|
|
42 |
3 |
p. 448-454
|
article
|
| 32 |
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study
|
Muller, M.P.
|
|
|
42 |
3 |
p. 535-540
|
article
|
| 33 |
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions – A cross-sectional study in six EU member states
|
Buhl, Caroline
|
|
|
42 |
3 |
p. 556-563
|
article
|
| 34 |
Racial and ethnic differences in COVID-19 vaccine readiness among adults in the United States, January 2021–April 2023
|
Kranzler, Elissa C.
|
|
|
42 |
3 |
p. 410-414
|
article
|
| 35 |
Social determinants of health and vaccine uptake in pregnancy: Disparities in a diverse, predominately foreign-born population
|
Agasse, Eva
|
|
|
42 |
3 |
p. 529-534
|
article
|
| 36 |
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection
|
To, Albert
|
|
|
42 |
3 |
p. 598-607
|
article
|
| 37 |
The Social Ecology of Health Beliefs and Misinformation Framework: Examining the impact of misinformation on vaccine uptake through individual and sociological factors
|
Enyinnaya, Joy C.
|
|
|
42 |
3 |
p. 455-463
|
article
|
| 38 |
Vaccination equity and the role of community pharmacy in the United States: A qualitative study
|
Carroll, Joni C.
|
|
|
42 |
3 |
p. 564-572
|
article
|
| 39 |
Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models
|
Kachko, Alla
|
|
|
42 |
3 |
p. 608-619
|
article
|
Journal description